MENU
IKT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Inhibikase Therapeutics (IKT) Ownership - Who owns Inhibikase Therapeutics?
Profile
Industry
N/A
Address
3350 Riverwood Parkway SE
Phone
+1 678 392-3419
Employees
14
Web
https://www.inhibikase.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.73M
P/E Ratio
N/A
Total Cash
1.91M
Projected Growth
N/A
Total Debt
209.49K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IKT
Capitalization
8.73M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.91M
Total Cash/Share
0.26
Total Debt
209K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
6.78M
P/B Ratio
1.71
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.48K
Current Ratio
2.55
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
7.46M
Total Liabilities
4.29M
Total Volume MTD
N/A
Value
1
Gain YTD
5.512
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3350 Riverwood Parkway SE
Phone
+1 678 392-3419
Employees
14
Web
https://www.inhibikase.com